Trulieve Cannabis Corp. Quarterly Income Tax Expense (Benefit) in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Trulieve Cannabis Corp. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2020 to Q3 2024.
  • Trulieve Cannabis Corp. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $47.4M, a 29.3% increase year-over-year.
  • Trulieve Cannabis Corp. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $195M, a 28.1% increase year-over-year.
  • Trulieve Cannabis Corp. annual Income Tax Expense (Benefit) for 2023 was $151M, a 7.36% decline from 2022.
  • Trulieve Cannabis Corp. annual Income Tax Expense (Benefit) for 2022 was $163M, a 12.1% increase from 2021.
  • Trulieve Cannabis Corp. annual Income Tax Expense (Benefit) for 2021 was $146M, a 54.3% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $195M $47.4M +$10.7M +29.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-05
Q2 2024 $185M $47.2M +$13.4M +39.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $171M $55.4M +$20M +56.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $151M $45.4M -$1.22M -2.61% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $153M $36.6M +$8.27M +29.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 $144M $33.8M -$11.4M -25.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $156M $35.5M -$7.66M -17.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $163M $46.6M +$6.18M +15.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $157M $28.4M -$13.2M -31.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $170M $45.2M +$16.1M +55.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $154M $43.1M +$8.58M +24.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $146M $40.5M +$13.1M +48% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $133M $41.6M +$15.7M +60.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $117M $29.1M +$5.83M +25% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $111M $34.5M +$16.7M +93.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $94.5M $27.3M Oct 1, 2020 Dec 31, 2020 10-K/A 2023-04-05
Q3 2020 $25.9M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $23.3M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $17.9M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.